Our results showed that MTDH, as a cell surface protein, is significantly associated with the mortality of patients with reproduction malignancies (HR = 3.647), including breast cancer (HR = 2.728), ovarian cancer (HR = 4.525), cervical cancer (HR = 2.524) and endometrial cancer (HR = 2.524). This evidence concerns the gene MTDH and ovarian carcinoma.